Pharmacokinetics of doxycycline after oral administration of multiple doses in dogs

J Vet Pharmacol Ther. 2021 May;44(3):326-332. doi: 10.1111/jvp.12926. Epub 2020 Oct 30.

Abstract

The aim of this study was to determine the pharmacokinetic parameters of doxycycline in dogs and assess the efficacy of an oral drug dosage regimen of 10 mg/kg daily for 28 days through Pharmacokinetic/Pharmacodynamic (PK/PD) target analysis based on Monte Carlo simulation, using previously published data for the zoonotic pathogen Staphylococcus pseudintermedius. After a multiple-dosage regimen, the accumulation index was 1.88 ± 0.82. The Cmaxss and Cminss values were 5.18 ± 1.81 µg/ml and 1.91 ± 1.35 µg/ml, respectively. There were statistically significant differences for Cmax, Cmin at 24 hr, MRTt, AUCt and AUC∞ between days 1 and 28. The Cminss value was over the MIC of the principal pathogens, and Cmaxss was higher than the resistance values (>2 μg/ml). For AUC/MIC indices of 12, 25 and 40, the cumulative fraction responses (CFR) were 94.01%, 69.55% and 60.86%, respectively; for an MIC value of 2 µg/ml, the corresponding probability of target attainment (PTA) was 99.94%, 84.78% and 45.16%, respectively. Doxycycline was used against numerous localized infections in different organs and tissues. For the strains with MIC < 1 μg/mL, PTA was close to 100%, even for the most demanding ones, specifically 94.98% for an index of 40% and 99.9% for an index of 25.

Keywords: Monte Carlo; dogs; doxycycline; multiple doses; pharmacokinetic-pharmacodynamics.

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Bacterial Agents*
  • Dogs
  • Doxycycline*
  • Microbial Sensitivity Tests / veterinary
  • Monte Carlo Method
  • Staphylococcus

Substances

  • Anti-Bacterial Agents
  • Doxycycline

Supplementary concepts

  • Staphylococcus pseudintermedius